Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic

Table 1 Vaccine information

Vaccine classification	Name of vaccine approved by the WHO	Vaccine research and development unit
Inactivated vaccine	BBIBP-CorV	Sinopharm
Inactivated vaccine	CoronaVac	Sinovac Biotech
Inactivated vaccine	COVAXIN	Bharat Biotech International
Viral vector vaccine	AZD1222	AstraZeneca-University of Oxford
Viral vector vaccine	Ad26.COV-2-S	Johnson & Johnson
Viral vector vaccine	COVISHIELD	Serum Institute of India
Protein subunit vaccine	NVX-CoV2373	Novavax
Protein subunit vaccine	COVOVAX	Serum Institute of India
mRNA vaccine	BNT162b2	Pfizer-BioNTech
mRNA vaccine	mRNA-1273	Moderna

WHO: World Health Organization; mRNA: Messenger ribonucleic acid.

Table 2 Drugs information

Therapeutic drugs	Mechanism
Remdesivir	Inhibiting virus replication
Molnupiravir	Inhibiting virus replication
Paxlovid	Inhibiting virus replication
Bamlanivimab/Etesevimab	Blocking the binding of viruses to host cells
Casirivimab/Imdevimab	Blocking the binding of viruses to host cells
Cyclosporin	Inhibiting overactivated immune system
Recovery period plasma therapy	Antibodies that neutralize viruses